• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.人β-半乳糖苷酶的晶体结构:GM1 神经节苷脂贮积症和黏多糖贮积症 B 型的结构基础。
J Biol Chem. 2012 Jan 13;287(3):1801-12. doi: 10.1074/jbc.M111.293795. Epub 2011 Nov 28.
2
[Structural basis for β-galactosidase associated with lysosomal disease].[与溶酶体疾病相关的β-半乳糖苷酶的结构基础]
Yakugaku Zasshi. 2013;133(5):509-17. doi: 10.1248/yakushi.13-00001-1.
3
Structural basis of pharmacological chaperoning for human β-galactosidase.人β-半乳糖苷酶药物伴侣作用的结构基础
J Biol Chem. 2014 May 23;289(21):14560-8. doi: 10.1074/jbc.M113.529529. Epub 2014 Apr 15.
4
DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts.DLHex-DGJ,一种新型 1-去氧半乳糖基神经氨酸衍生物,对人 G(M1)-神经节苷脂贮积症成纤维细胞具有药理学伴侣活性。
Mol Genet Metab. 2010 Jul;100(3):262-8. doi: 10.1016/j.ymgme.2010.03.019. Epub 2010 Mar 28.
5
Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.患有莫尔基奥B病或婴儿型GM1神经节苷脂贮积症患者的成纤维细胞弹性纤维组装受损,这与β-半乳糖苷酶67-kD剪接变体的缺乏有关。
Am J Hum Genet. 2000 Jul;67(1):23-36. doi: 10.1086/302968. Epub 2000 Jun 6.
6
A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis.一种双环 1-脱氧半乳糖基氮杂环庚烷衍生物,作为 GM1 神经节苷脂贮积症的新型药理学伴侣。
Mol Ther. 2013 Mar;21(3):526-32. doi: 10.1038/mt.2012.263. Epub 2013 Jan 22.
7
Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.用于GM1神经节苷脂贮积症的酶替代疗法:利用新型β-半乳糖苷酶:RTB凝集素融合蛋白的摄取、溶酶体激活及细胞疾病纠正
Mol Genet Metab. 2016 Feb;117(2):199-209. doi: 10.1016/j.ymgme.2015.12.002. Epub 2015 Dec 8.
8
Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.GM1神经节苷脂贮积症和B型黏多糖贮积症Ⅳ型的分子基础。溶酶体β-半乳糖苷酶和非溶酶体β-半乳糖苷酶样蛋白的结构-功能研究。
Biochim Biophys Acta. 1999 Oct 8;1455(2-3):85-103. doi: 10.1016/s0925-4439(99)00075-7.
9
(5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.(5aR)-5a-C-戊基-4-表异法戈明:一种强大的溶酶体β-半乳糖苷酶抑制剂,也是与GM1神经节苷脂贮积症和B型莫尔基奥氏病相关突变的显著伴侣分子。
Eur J Med Chem. 2017 Jan 27;126:160-170. doi: 10.1016/j.ejmech.2016.09.095. Epub 2016 Sep 29.
10
Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease.莫尔基奥B病患者中突变型β-半乳糖苷酶的底物特异性失衡。
Mol Genet Metab. 2003 Jan;78(1):51-8. doi: 10.1016/s1096-7192(02)00199-3.

引用本文的文献

1
Species-selective activation of a β-galactosidase fluorogenic probe.β-半乳糖苷酶荧光探针的物种选择性激活
Sci Rep. 2025 Jul 2;15(1):23657. doi: 10.1038/s41598-025-08443-y.
2
Genotype-Phenotype Relations for the Dystonia-Parkinsonism Genes , , , , and : MDSGene Systematic Review.肌张力障碍-帕金森综合征相关基因、、、和的基因型-表型关系:MDS基因系统评价
Int J Mol Sci. 2025 Apr 25;26(9):4074. doi: 10.3390/ijms26094074.
3
Tandem activated caged galactoside prodrugs: advancing beyond single galactosidase dependence.串联激活的笼形半乳糖苷前药:超越对半乳糖苷酶的单一依赖。
Chem Sci. 2025 Mar 18;16(17):7173-7190. doi: 10.1039/d5sc00722d. eCollection 2025 Apr 30.
4
Clinical and genetic analysis of a Chinese family with GM1 gangliosidosis caused by a novel mutation in GLB1 gene.一个因GLB1基因新突变导致GM1神经节苷脂贮积症的中国家庭的临床与遗传学分析
Front Pediatr. 2025 Jan 20;13:1507098. doi: 10.3389/fped.2025.1507098. eCollection 2025.
5
A  transgene with enhanced therapeutic potential for the preclinical development of  gene therapy to treat mucopolysaccharidosis type IVB.一种具有增强治疗潜力的转基因,用于治疗IVB型黏多糖贮积症的基因治疗临床前开发。
Mol Ther Methods Clin Dev. 2024 Aug 6;32(3):101313. doi: 10.1016/j.omtm.2024.101313. eCollection 2024 Sep 12.
6
Mutations in Glycosyltransferases and Glycosidases: Implications for Associated Diseases.糖基转移酶和糖苷酶中的突变:对相关疾病的影响。
Biomolecules. 2024 Apr 19;14(4):497. doi: 10.3390/biom14040497.
7
Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric β-Galactosidase correctors.验证一种基于 HaloTag 的高灵敏度检测方法,用于评估新型别构β-半乳糖苷酶校正剂的效力。
PLoS One. 2023 Nov 29;18(11):e0294437. doi: 10.1371/journal.pone.0294437. eCollection 2023.
8
Function and Structure of GH35 β-Galactosidase LBCZ_0230 with High Hydrolytic Activity to Lacto--biose I and Galacto--biose.对乳糖-双糖I和半乳糖-双糖具有高水解活性的GH35β-半乳糖苷酶LBCZ_0230的功能与结构
J Appl Glycosci (1999). 2023 May 20;70(2):43-52. doi: 10.5458/jag.jag.JAG-2022_0014. eCollection 2023.
9
Processed pseudogene insertion in GLB1 causes Morquio B disease by altering intronic splicing regulatory landscape.GLB1基因中加工后的假基因插入通过改变内含子剪接调控格局导致莫尔基奥B病。
NPJ Genom Med. 2022 Jul 26;7(1):44. doi: 10.1038/s41525-022-00315-y.
10
Activatable Second Near-Infrared Fluorescent Probes: A New Accurate Diagnosis Strategy for Diseases.可激活的第二代近红外荧光探针:疾病诊断的新策略
Biosensors (Basel). 2021 Nov 2;11(11):436. doi: 10.3390/bios11110436.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.振荡模式下收集的X射线衍射数据的处理。
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Expression, purification, crystallization and preliminary X-ray crystallographic analysis of human β-galactosidase.人β-半乳糖苷酶的表达、纯化、结晶及初步X射线晶体学分析
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Jan 1;68(Pt 1):73-7. doi: 10.1107/S1744309111047920. Epub 2011 Dec 24.
3
GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings.GM1神经节苷脂贮积症和莫尔基奥B病:基因改变与临床发现的最新进展
Biochim Biophys Acta. 2011 Jul;1812(7):782-90. doi: 10.1016/j.bbadis.2011.03.018. Epub 2011 Apr 7.
4
Crystal structures of Trichoderma reesei β-galactosidase reveal conformational changes in the active site.里氏木霉β-半乳糖苷酶的晶体结构揭示了活性部位的构象变化。
J Struct Biol. 2011 Apr;174(1):156-63. doi: 10.1016/j.jsb.2010.11.024. Epub 2010 Dec 3.
5
Evidence that family 35 carbohydrate binding modules display conserved specificity but divergent function.有证据表明,35 家族碳水化合物结合模块具有保守的特异性,但功能存在差异。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3065-70. doi: 10.1073/pnas.0808972106. Epub 2009 Feb 13.
6
GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.GM1神经节苷脂贮积症:临床、分子及治疗方面的综述
Mol Genet Metab. 2008 Aug;94(4):391-396. doi: 10.1016/j.ymgme.2008.04.012. Epub 2008 Jun 3.
7
Cold-active beta-galactosidase from Arthrobacter sp. C2-2 forms compact 660 kDa hexamers: crystal structure at 1.9A resolution.节杆菌属C2-2菌株的冷活性β-半乳糖苷酶形成紧密的660 kDa六聚体:1.9埃分辨率的晶体结构
J Mol Biol. 2005 Oct 21;353(2):282-94. doi: 10.1016/j.jmb.2005.08.028.
8
Coot: model-building tools for molecular graphics.Coot:分子图形的模型构建工具。
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32. doi: 10.1107/S0907444904019158. Epub 2004 Nov 26.
9
Crystal structures of beta-galactosidase from Penicillium sp. and its complex with galactose.青霉属β-半乳糖苷酶的晶体结构及其与半乳糖的复合物
J Mol Biol. 2004 Nov 5;343(5):1281-92. doi: 10.1016/j.jmb.2004.09.012.
10
Refinement of macromolecular structures by the maximum-likelihood method.用最大似然法优化大分子结构。
Acta Crystallogr D Biol Crystallogr. 1997 May 1;53(Pt 3):240-55. doi: 10.1107/S0907444996012255.

人β-半乳糖苷酶的晶体结构:GM1 神经节苷脂贮积症和黏多糖贮积症 B 型的结构基础。

Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.

机构信息

From the Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

出版信息

J Biol Chem. 2012 Jan 13;287(3):1801-12. doi: 10.1074/jbc.M111.293795. Epub 2011 Nov 28.

DOI:10.1074/jbc.M111.293795
PMID:22128166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3265862/
Abstract

G(M1) gangliosidosis and Morquio B are autosomal recessive lysosomal storage diseases associated with a neurodegenerative disorder or dwarfism and skeletal abnormalities, respectively. These diseases are caused by deficiencies in the lysosomal enzyme β-d-galactosidase (β-Gal), which lead to accumulations of the β-Gal substrates, G(M1) ganglioside, and keratan sulfate. β-Gal is an exoglycosidase that catalyzes the hydrolysis of terminal β-linked galactose residues. This study shows the crystal structures of human β-Gal in complex with its catalytic product galactose or with its inhibitor 1-deoxygalactonojirimycin. Human β-Gal is composed of a catalytic TIM barrel domain followed by β-domain 1 and β-domain 2. To gain structural insight into the molecular defects of β-Gal in the above diseases, the disease-causing mutations were mapped onto the three-dimensional structure. Finally, the possible causes of the diseases are discussed.

摘要

G(M1)神经节苷脂贮积症和 Morquio B 型是两种常染色体隐性溶酶体贮积病,分别与神经退行性疾病或矮小症和骨骼异常有关。这些疾病是由溶酶体酶β-D-半乳糖苷酶(β-Gal)的缺乏引起的,导致β-Gal 底物 G(M1)神经节苷脂和硫酸角质素的积累。β-Gal 是一种外糖苷酶,可催化末端β-linked 半乳糖残基的水解。本研究展示了人β-Gal 与其催化产物半乳糖或抑制剂 1-脱氧半乳糖基氮杂环庚烷的复合物的晶体结构。人β-Gal 由一个催化 TIM 桶结构域和β-结构域 1 和β-结构域 2 组成。为了深入了解上述疾病中β-Gal 的分子缺陷,将致病突变映射到三维结构上。最后,讨论了疾病的可能原因。